Gene · 2355
Papers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH. | Diabetologia | 2023 | 37233759 | PubTator, text mining | PubMed |
| Pathophysiological role of BACH transcription factors in digestive system diseases. | Front Physiol | 2023 | 37228820 | PubTator, text mining | PubMed |
| UnWNTing the Heart: Targeting WNT Signaling in Pulmonary Arterial Hypertension. | Circ Res | 2023 | 37228239 | PubTator, text mining | PubMed |
| Eubacterium rectale Improves the Efficacy of Anti-PD1 Immunotherapy in Melanoma via l-Serine-Mediated NK Cell Activation. | Research (Wash D C) | 2023 | 37223471 | PubTator, text mining | PubMed |
| A complex structural variant near SOX3 causes X-linked split-hand/foot malformation. | HGG Adv | 2023 | 37216008 | PubTator, text mining | PubMed |
| LRP5-/6 gene polymorphisms and its association with risk of abnormal bone mass in postmenopausal women. | J Orthop Surg Res | 2023 | 37202775 | PubTator, text mining | PubMed |
Retraction notice to "MicroRNA-30e promotes hepatocyte proliferation and inhibits apoptosis in cecal ligation and puncture-induced sepsis through the JAK/STAT signaling pathway by binding to FOSL2" [Biomed. Pharmacother. 104 (2018) 411-419]. | Biomed Pharmacother | 2023 | 37183051 | PubTator, text mining | PubMed |
| INKA2-AS1 Is a Potential Promising Prognostic-Related Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma. | Mediators Inflamm | 2023 | 37181806 | PubTator, text mining | PubMed |
| Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis. | Front Cell Dev Biol | 2023 | 37181747 | PubTator, text mining | PubMed |
| Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome. | Clin Epigenetics | 2023 | 37179374 | PubTator, text mining | PubMed |
| FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer. | Int J Mol Sci | 2023 | 37176013 | PubTator, text mining | PubMed |
| Integration of ATAC-Seq and RNA-Seq reveals FOSL2 drives human liver progenitor-like cell aging by regulating inflammatory factors. | BMC Genomics | 2023 | 37173651 | PubTator, text mining | PubMed |
| PcTrim prevents early infection with white spot syndrome virus by inhibiting AP1-induced endocytosis. | Cell Commun Signal | 2023 | 37158899 | PubTator, text mining | PubMed |
| Hypoxia Induces M2 Macrophages to Express VSIG4 and Mediate Cardiac Fibrosis After Myocardial Infarction. | Theranostics | 2023 | 37153746 | PubTator, text mining | PubMed |
| Disruption of the tumor suppressor-like activity of aryl hydrocarbon receptor by arsenic in epithelial cells and human lung cancer. | Int J Biol Sci | 2023 | 37151890 | PubTator, text mining | PubMed |
| High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD. | EMBO J | 2023 | 37143403 | PubTator, text mining | PubMed |
| Applying causal discovery to single-cell analyses using CausalCell. | Elife | 2023 | 37129360 | PubTator, text mining | PubMed |
| MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine. | Mol Ther Nucleic Acids | 2023 | 37128277 | PubTator, text mining | PubMed |
| PGE2 alters chromatin through H2A.Z-variant enhancer nucleosome modification to promote hematopoietic stem cell fate. | Proc Natl Acad Sci U S A | 2023 | 37126722 | PubTator, text mining | PubMed |
| Bromodomain protein BRD8 regulates cell cycle progression in colorectal cancer cells through a TIP60-independent regulation of the pre-RC complex. | iScience | 2023 | 37123243 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2355/papers?page=18